Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
Now, if you look at the last five years, and especially the last two, the opportunity to sell insulin for a profit has basically completely fallen apart. So you've got regulation that came in after the public outcry, so there's real price caps on what you can sell insulin for now. Biosimilars also came in.
0
💬
0
Comments
Log in to comment.
There are no comments yet.